$ --

The second quarter of 2022 showcased stagnancy in the Levocetirizine Dihydrochloride Prices in the North American market. Antihistamine properties of Levocetirizine governed the market sentiments in the regional market. The US market remained disrupted throughout the quarter as the country faced major port congestion. Labour and vessel shortages in the regional market occasionally impacted the transportation of API with the drug-producing companies. Furthermore, inflation occurred in the market, consequently influencing the production cost of Levocetirizine in the North American market. The Spring season led to high chances of allergic reactions in the country, especially among older people, consequently increasing the demand forLevocetirizine in the North American market. 

For more information

E-Mail:- sales@chemanalyst.com

websites:- https://www.chemanalyst.com/Pricing-data/lovocetirizine-dihydrochloride-1436

Contact No:- +13322586602